Carmella Evans-Molina
Endocrinology, Diabetes & Metabolism · Indianapolis, INNPI 1306063078
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Sanofi US Services Inc. accounts for 82.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $45,034, 6.3 times the $7,125 reported in 2019. Among endocrinology, diabetes & metabolism clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $2026.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$45K
- E.r. Squibb & Sons, L.L.C.$5K
- Dompe US, Inc.$3K
- Pfizer$2K
- Eli Lilly$78
Across 10 payments — averaging $623,925 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$6M
- Astellas Pharma Inc$248K
What the payments were for
- Consulting fees$15,39228%
- Speaking & faculty fees$14,49827%
- Travel & lodging$24,43445%
- Food & beverage$3851%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 7 | $45,034 |
| E.r. Squibb & Sons, L.L.C. | 11 | $5,405 |
| Dompe US, Inc. | 3 | $2,550 |
| Pfizer | 5 | $1,642 |
| Eli Lilly | 1 | $78 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$54,709 in reported general payments places this provider in the 90th percentile of 134 endocrinology, diabetes & metabolism providers in Indiana.
See all endocrinology, diabetes & metabolism providers in Indiana →
Other endocrinology, diabetes & metabolism in Indianapolis
- Ernest AsamoahIndianapolis$959K
- Hisham AllababidiIndianapolis$195K
- Michael EconsIndianapolis$74K
- Manuel Bello SeguraIndianapolis$44K
- Moazzam HabibIndianapolis$29K
- James EdmondsonIndianapolis$10K
- James ScheidlerIndianapolis$8K
- Cary MariashIndianapolis$6K
- Jayender ChintaparthiIndianapolis$5K
- Munro PeacockIndianapolis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.